Cardiovascular Disease Risk Factors and Healthy Lifestyle Behaviours in Patients with Ankylosing Spondylitis
Launched by KIRSEHIR AHI EVRAN UNIVERSITESI · Oct 18, 2024
Trial Information
Current as of August 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is examining how much patients with ankylosing spondylitis (AS) know about the risk factors for heart disease and healthy lifestyle choices. The goal is to understand their knowledge and habits related to physical activity, which can help improve their overall health. Right now, the study is looking for volunteers, specifically individuals aged 18-65 who have been diagnosed with AS and have been stable on their medications for at least three months.
If you join the study, you’ll help researchers learn more about how to support people with AS in managing their heart health. It’s important to note that certain individuals cannot participate, such as those with uncontrolled heart or lung conditions, pregnant women, or those who have had recent surgery or cancer. By taking part, you could contribute valuable information that might help improve care for others with similar conditions in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosis of ankylosing spondylitis according to ASAS diagnostic criteria
- • Being aged 18-65
- • Stable medication use for at least 3 months
- • Voluntary participation in the study
- Exclusion Criteria:
- • Having uncontrolled cardiopulmonary disease
- • Being pregnant
- • Having undergone recent surgery
- • Presence of malignancy
About Kirsehir Ahi Evran Universitesi
Kırşehir Ahi Evran University is a distinguished academic institution in Turkey, renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, the university leverages its expertise in various healthcare fields to facilitate innovative research initiatives aimed at improving patient outcomes and advancing scientific knowledge. With a focus on collaboration and ethical standards, Kırşehir Ahi Evran University actively engages in clinical trials that encompass a broad spectrum of medical disciplines, fostering an environment that encourages rigorous scientific inquiry and the translation of research findings into clinical practice.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kirsehir, , Turkey
Patients applied
Trial Officials
Merve Firat
Principal Investigator
Kirsehir Ahi Evran University
Basak Kavalci Kol
Study Chair
Kirsehir Ahi Evran University
Figen Tuncay
Study Chair
Kirsehir Ahi Evran University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported